<DOC>
	<DOCNO>NCT00193869</DOCNO>
	<brief_summary>The study aim pilot viability full scale randomise comparison 2 steroid dos malignant spinal cord compression , establish safety high dose dexamethasone set Australia , test web registration randomisation compare different functional outcome measure .</brief_summary>
	<brief_title>SuperDEX Trial ( Comparison Two Doses Dexamethasone Malignant Spinal Cord Compression Treated Radiotherapy ) .</brief_title>
	<detailed_description>Malignant spinal cord compression ( MSCC ) uncommon condition estimate annual incidence 2.5 per 100,000 . It dread complication malignancy severe impact paralysis sphincter disturbance quality duration survival . Rat model demonstrate effectiveness high dos steroid . Only three randomise control trial ( RCTs ) publish . The first compare radiotherapy laminectomy plus radiotherapy series 29 patient fail show significant differences The widespread commonly use dose Dexamethasone Australia time 16 mg/24 hr main concern implement high dos toxicity profile report small randomised comparison available time.In view conflict standard Australian practice versus publish ( overseas ) guideline , randomise comparison propose Australia . This study pilot study initiate determine viability large trial , pilot use web technology trial conduct determine clinically useful outcome measure apart simple ambulation rate . Comparisons : Patients randomise receive either 16mg/24hr 96mg/24hr dexamethasone .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Spinal Cord Compression</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Malignant spinal cord compression least one pain , weakness , sensory disturbance sphincter disturbance Histology require prior biopsy proven malignancy Any stage Age &gt; 16 year ECOG 13 prior cord compression event Minimum power 1 5 point scale Must paraplegic Minimum expect survival 2 month Relevant minimum lab value Patients capable childbearing use adequate contraception Written inform consent Prior radiotherapy within vertebral±one level affect cord compression Prior treatment spinal cord compression current level Histology lymphoma myeloma Power le 1 5 More 12 hour initiation dexamethasone &gt; 4mg/24hr Preexisting comorbid condition – peptic ulceration cardiac failure Allergy study medication Multilevel cord compression meningeal carcinomatosis Pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Radiotherapy</keyword>
	<keyword>Dose fractionation</keyword>
</DOC>